CYTK
Price
$39.23
Change
+$0.55 (+1.42%)
Updated
Jul 17, 04:19 PM (EDT)
Capitalization
4.62B
14 days until earnings call
MAIA
Price
$1.81
Change
+$0.10 (+5.85%)
Updated
Jul 17, 02:48 PM (EDT)
Capitalization
52.62M
19 days until earnings call
Interact to see
Advertisement

CYTK vs MAIA

Header iconCYTK vs MAIA Comparison
Open Charts CYTK vs MAIABanner chart's image
Cytokinetics
Price$39.23
Change+$0.55 (+1.42%)
Volume$300
Capitalization4.62B
MAIA Biotechnology
Price$1.81
Change+$0.10 (+5.85%)
Volume$200
Capitalization52.62M
CYTK vs MAIA Comparison Chart in %
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MAIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. MAIA commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a StrongBuy and MAIA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 17, 2025
Stock price -- (CYTK: $38.68 vs. MAIA: $1.71)
Brand notoriety: CYTK and MAIA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 104% vs. MAIA: 32%
Market capitalization -- CYTK: $4.62B vs. MAIA: $52.62M
CYTK [@Biotechnology] is valued at $4.62B. MAIA’s [@Biotechnology] market capitalization is $52.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $300.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileMAIA’s FA Score has 0 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • MAIA’s FA Score: 0 green, 5 red.
According to our system of comparison, CYTK is a better buy in the long-term than MAIA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 5 TA indicator(s) are bullish while MAIA’s TA Score has 3 bullish TA indicator(s).

  • CYTK’s TA Score: 5 bullish, 4 bearish.
  • MAIA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CYTK is a better buy in the short-term than MAIA.

Price Growth

CYTK (@Biotechnology) experienced а +5.61% price change this week, while MAIA (@Biotechnology) price change was -14.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.24%. For the same industry, the average monthly price growth was +13.83%, and the average quarterly price growth was +38.48%.

Reported Earning Dates

CYTK is expected to report earnings on Oct 30, 2025.

MAIA is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (+2.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($4.62B) has a higher market cap than MAIA($52.6M). MAIA YTD gains are higher at: -13.636 vs. CYTK (-17.772). MAIA has higher annual earnings (EBITDA): -24.75M vs. CYTK (-513.62M). CYTK has more cash in the bank: 938M vs. MAIA (10.9M). CYTK has higher revenues than MAIA: CYTK (19.2M) vs MAIA (0).
CYTKMAIACYTK / MAIA
Capitalization4.62B52.6M8,781%
EBITDA-513.62M-24.75M2,075%
Gain YTD-17.772-13.636130%
P/E RatioN/AN/A-
Revenue19.2M0-
Total Cash938M10.9M8,606%
Total Debt791MN/A-
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
81
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKMAIA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 9 days ago
88%
Declines
ODDS (%)
Bearish Trend 18 days ago
78%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MAIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYRBY4.760.13
+2.81%
Cyrela Brazil Realty S.A.
AHOTF0.34N/A
+1.26%
American Hotel Income Properties REIT LP
HLLGY50.79N/A
N/A
Hella Gmbh & Co Kgaa
MVMDF0.02N/A
-2.00%
Mountain Valley MD Holdings Inc.
SER5.15-0.15
-2.83%
Serina Therapeutics

MAIA and

Correlation & Price change

A.I.dvisor tells us that MAIA and ARDX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MAIA and ARDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAIA
1D Price
Change %
MAIA100%
N/A
ARDX - MAIA
32%
Poorly correlated
+2.22%
IPSC - MAIA
28%
Poorly correlated
+3.39%
RZLT - MAIA
27%
Poorly correlated
+4.70%
GOVX - MAIA
26%
Poorly correlated
+6.43%
CYTK - MAIA
26%
Poorly correlated
+1.76%
More